RYTM — RHYTHM PHARMACEUTICALS INC

Ownership history in Engineers Gate Manager LP  ·  7 quarters on record

This page tracks every 13F SEC filing in which Engineers Gate Manager LP reported a position in RHYTHM PHARMACEUTICALS INC (RYTM). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.03% (2021 Q1)
Avg. % of fund
0.02%
First filed
2021 Q1
Last filed
2025 Q3
Quarters held
7
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 REDUCED 13,775 -3,901 -22.1% 0.02% $1.4M $100.99
2025 Q2 REDUCED 17,676 -4,207 -19.2% 0.01% $1.1M $63.19
2025 Q1 ADDED 21,883 +2,700 +14.1% 0.02% $1.2M $52.97
2024 Q4 ADDED 19,183 +6,112 +46.8% 0.02% $1.1M $55.98
3 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    RYTM price (monthly, adj. close)

Other funds also holding RYTM

As of 2025 Q4 — sorted by position size

Checkpoint Capital L.P. 33.18% NEA Management Company, LLC 3Y 7Y 15.88% RA CAPITAL MANAGEMENT, L.P. 3Y 7Y 7.31% PERCEPTIVE ADVISORS LLC 3Y 7Y 4.86% Nan Fung Group Holdings Ltd 3Y 4.71% Opaleye Management Inc. 3Y 7Y 4.66% Sio Capital Management, LLC 3Y 7Y 4.47% Rock Springs Capital Management LP 3Y 7Y 3.81% BAKER BROS. ADVISORS LP 3Y 7Y 3.51% Integral Health Asset Management, LLC 3Y 2.52%
← Back to Engineers Gate Manager LP Holdings